Medchemexpress LLC:1246725 [23-006718] 29 compounds for national center for advancing translational sciences (ncats) NS3-NS2B TOX21 research project
Ended Purchase Order Awarded
- Contract number
- 75N95023P00848
- Awardee
-
Medchemexpress LLC UEI EWMQQNKJ3YZ8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,700
Award facts
- Contract value 100% obligated
- $24,700.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Monmouth Junction, South Brunswick Township, NJ 08852, USA
Award details come from SAM.gov/FPDS.
About this award
Medchemexpress LLC has been awarded a firm fixed price purchase order valued at $24,700 by the National Institutes of Health's National Center for Advancing Translational Sciences to provide 29 compounds in support of the agency's Tox21 research project examining the NS3-NS2B complex. As part of its mission to translate scientific discoveries into clinical applications, NCATS utilizes screening programs like Tox21 to evaluate the effects of environmental chemicals on biological pathways related to toxicity. This small business set-aside contract will deliver test substances over a three-month period to the prime contractor's facility in Monmouth Junction, New Jersey to facilitate NCATS' ongoing work in this therapeutic area.
Quick answers
Who was awarded contract 75N95023P00848?
75N95023P00848 was awarded to Medchemexpress LLC by National Institute on Drug Abuse (National Institutes of Health) on September 22, 2023.
How much is contract 75N95023P00848 worth?
The government has obligated $24,700 on 75N95023P00848.
Which agency awarded contract 75N95023P00848?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023P00848, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95023P00848 competed?
The extent of competition for 75N95023P00848 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award